Marty Makary has stepped down from his role, prompting the Trump administration to initiate the search for a new FDA commissioner.
The administration reportedly has a detailed wish list outlining the qualities and priorities they seek in the next leader of the FDA.
As the search unfolds, the implications for public health and regulatory policies will be closely watched by stakeholders across the healthcare landscape.